Hawkins (HWKN) Set to Announce Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) will be issuing its quarterly earnings data after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of $1.01 per share for the quarter.

Hawkins (NASDAQ:HWKN) last issued its quarterly earnings data on Wednesday, May 15th. The specialty chemicals company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.02). The firm had revenue of $223.02 million for the quarter, compared to the consensus estimate of $217.49 million. Hawkins had a return on equity of 19.41% and a net margin of 8.20%. On average, analysts expect Hawkins to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Hawkins Price Performance

Hawkins stock opened at $106.44 on Tuesday. The stock has a 50-day moving average price of $92.68 and a two-hundred day moving average price of $79.44. Hawkins has a 12 month low of $45.50 and a 12 month high of $110.53. The company has a market capitalization of $2.23 billion, a PE ratio of 29.65, a P/E/G ratio of 4.86 and a beta of 0.72. The company has a current ratio of 1.96, a quick ratio of 1.24 and a debt-to-equity ratio of 0.22.

Hawkins Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Friday, May 31st were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.60%. The ex-dividend date was Friday, May 31st. Hawkins’s dividend payout ratio is currently 17.83%.

Insider Buying and Selling

In related news, Director James A. Faulconbridge bought 2,000 shares of the business’s stock in a transaction on Monday, June 10th. The shares were purchased at an average cost of $86.47 per share, with a total value of $172,940.00. Following the acquisition, the director now owns 44,017 shares of the company’s stock, valued at $3,806,149.99. The purchase was disclosed in a filing with the SEC, which is available through this link. In other news, Director James A. Faulconbridge purchased 2,000 shares of the stock in a transaction on Monday, June 10th. The stock was purchased at an average price of $86.47 per share, for a total transaction of $172,940.00. Following the acquisition, the director now owns 44,017 shares in the company, valued at $3,806,149.99. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director James A. Faulconbridge purchased 1,300 shares of the company’s stock in a transaction dated Tuesday, June 4th. The stock was purchased at an average price of $86.50 per share, for a total transaction of $112,450.00. Following the transaction, the director now directly owns 38,117 shares in the company, valued at approximately $3,297,120.50. The disclosure for this purchase can be found here. Insiders purchased a total of 5,100 shares of company stock valued at $442,998 in the last three months. Insiders own 3.80% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, BWS Financial boosted their target price on shares of Hawkins from $74.00 to $96.00 and gave the stock a “buy” rating in a report on Friday, May 17th.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.